Abstract:Epidemiological findings suggest a potential role for anti-citrullinated protein antibodies (ACPAs) in rheumatoid arthritis (RA) pathogenesis. ACPA-positive RA is associated with unique genetical and environmental risk factors, in contrast to seronegative RA. ACPA-positive healthy individuals are at risk of developing RA and can develop joint pain and bone loss already before disease onset. ACPA injection triggered bone loss and pain-like behaviour in mice and, in the presence of additional arthritis inducers, exacerbated joint inflammation. In cell culture experiments, ACPAs could bind to and modulate a variety of cellular targets, such as macrophages, osteoclasts, synovial fibroblasts, neutrophil granulocytes, mast cells, dendritic cells and platelets, further underlying a potential role for these autoantibodies in triggering pathogenic pathways and providing clues for their mechanisms of action. Patient-derived ACPA clones have been characterised by unique cellular effects and multiple ways to act on the target cells. ACPAs might directly induce stimulatory signals by ligating key citrullinated cell surface molecules or, alternatively, act as immune complexes on Fc receptors and potentially other molecules that recognise carbohydrate moieties. On the contrary to experimentally manufactured ACPA clones, patient-derived ACPAs are highly promiscuous and cross-reactive, suggesting a simultaneous binding to a range of functionally relevant and irrelevant targets. Moreover, several ACPA clones recognise carbamylated or acetylated targets as well. These features complicate the identification and description of ACPA-induced pathogenic mechanisms. In the current review, we summarise recent data on the functional properties of patient-derived ACPAs and present mechanistic models on how these antibodies might contribute to RA pathogenesis.

Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis

Granzyme K+ CD8 T cells form a core population in inflamed human tissue

Arthritis progressors have a decreased frequency of circulating autoreactive T cells during the at-risk phase of rheumatoid arthritis

Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss

Single cell sequencing identifies clonally expanded synovial CD4+ TPH cells expressing GPR56 in rheumatoid arthritis

CD4+CD8αlow T cells in rheumatoid arthritis are clonally expanded and dependent on co-stimulation

A subset of antibodies targeting citrullinated proteins confers protection from rheumatoid arthritis

A Novel Hla-Drb1*10:01-Restricted T Cell Epitope from Citrullinated Type Ii Collagen Relevant to Rheumatoid Arthritis

Single-cell Sequencing of Immune Cells from Anticitrullinated Peptide Antibody Positive and Negative Rheumatoid Arthritis.

Citrullination of Nf-Kappa B P65 Promotes Its Nuclear Localization and Tlr-Induced Expression of Il-1 Beta and Tnf Alpha

Antibodies to Citrullinated Proteins: Molecular Interactions and Arthritogenicity

Single-cell transcriptomic profiling reveals a pathogenic role of cytotoxic CD4+ T cells in giant cell arteritis

Oral mucosal breaks trigger anti-citrullinated bacterial and human protein antibody responses in rheumatoid arthritis

Clonal associations between lymphocyte subsets and functional states in rheumatoid arthritis synovium

Cellular deconstruction of inflamed synovium defines diverse inflammatory phenotypes in rheumatoid arthritis

ACPA Mediates the Interplay Between Innate and Adaptive Immunity in Rheumatoid Arthritis.

A Citrullinated Antigenic Vaccine in Treatment of Autoimmune Arthritis

Mechanisms leading from systemic autoimmunity to joint-specific disease in rheumatoid arthritis

IL-6 and IL-27 negatively regulate CRTAM-expressing CD4+ T-cells associated with lymphoid-driven synovitis.

CCR9+CD4+ T cells are associated with disease activity in patients with rheumatoid arthritis

Current view on the pathogenic role of anti-citrullinated protein antibodies in rheumatoid arthritis